Clinical Trials Logo

Small Cell of the Bladder clinical trials

View clinical trials related to Small Cell of the Bladder.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT03430895 Completed - Clinical trials for Metastatic Bladder Cancer

Evaluating Immune Therapy, Durvalumab (MEDI4736) With Tremelimumab for Metastatic, Non-transitional Cell Carcinoma of the Urinary Tract

Start date: January 31, 2018
Phase: Phase 2
Study type: Interventional

This study is being done test to test the safety and effectiveness of durvalumab combined with tremelimumab in patients who have a rare form of cancer of the urinary tract.